These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16564844)

  • 1. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Gandorfer A; Kampik A
    Am J Ophthalmol; 2006 Apr; 141(4):784-5; author reply 785. PubMed ID: 16564844
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous.
    Takano A; Hirata A; Inomata Y; Kawaji T; Nakagawa K; Nagata S; Tanihara H
    Am J Ophthalmol; 2005 Oct; 140(4):654-60. PubMed ID: 16140249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.
    Hermel M; Prenner J; Alabdulrazzak M; Dailey W; Hartzer M
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):331-4. PubMed ID: 19034484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic vitreolysis in diabetic retinopathy.
    El-Asrar AM; Al-Mezain HS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):406-9. PubMed ID: 20939804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Assessment of Pharmacologic Vitreolysis in Rabbits With the Digital Fluoroscopy System.
    Bae JH; Park HS; Kim JM; Lee BR; Lee SC; Tandogan T; Auffarth GU; Koss MJ; Choi CY
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4817-22. PubMed ID: 26218910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants.
    Gandorfer A; Ulbig M; Kampik A
    Eye (Lond); 2002 Jan; 16(1):95-7. PubMed ID: 11913902
    [No Abstract]   [Full Text] [Related]  

  • 7. Microplasmin-assisted vitrectomy.
    Gandorfer A
    Dev Ophthalmol; 2009; 44():26-30. PubMed ID: 19494649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravitreal enzyme therapy and early transplantation of the vitreous body in experimental hemophthalmos].
    Lebekhov PI; Faĭnshteĭn EIa
    Vestn Oftalmol; 1980; (2):26-8. PubMed ID: 6446184
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effect of plasmin on the vitreolysis in rabbit eyes.
    Kim NJ; Yu HG; Yu YS; Chung H
    Korean J Ophthalmol; 2004 Jun; 18(1):35-40. PubMed ID: 15255235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.
    Wang ZL; Zhang X; Xu X; Sun XD; Wang F
    Retina; 2005 Jan; 25(1):38-43. PubMed ID: 15655439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous.
    Hikichi T; Yanagiya N; Kado M; Akiba J; Yoshida A
    Retina; 1999; 19(1):55-8. PubMed ID: 10048374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic induction of posterior vitreous detachment in the rabbit.
    Verstraeten TC; Chapman C; Hartzer M; Winkler BS; Trese MT; Williams GA
    Arch Ophthalmol; 1993 Jun; 111(6):849-54. PubMed ID: 8512489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes.
    Wu WC; Liu CH; Chen CC; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
    Mol Vis; 2012; 18():2361-70. PubMed ID: 23049236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonclinical safety and pharmacokinetics of intravitreally administered human-derived plasmin in rabbits and minipigs.
    Proksch JW; Driot JY; Vandeberg P; Ward KW
    J Ocul Pharmacol Ther; 2008 Jun; 24(3):320-32. PubMed ID: 18476803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological vitrectomy.
    Tanaka M; Qui H
    Semin Ophthalmol; 2000 Mar; 15(1):51-61. PubMed ID: 10749315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes and treatment of vitreous hemorrhage.
    Goff MJ; McDonald HR; Johnson RN; Ai E; Jumper JM; Fu AD
    Compr Ophthalmol Update; 2006; 7(3):97-111. PubMed ID: 16882398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic vitreous surgery.
    Trese MT
    Semin Ophthalmol; 2000 Jun; 15(2):116-21. PubMed ID: 11309736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.
    Hermel M; Dailey W; Trese M; Hartzer MK
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):37-46. PubMed ID: 20680641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic vitreodynamics and molecular flux.
    Goldenberg DT; Trese MT
    Dev Ophthalmol; 2009; 44():31-36. PubMed ID: 19494650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel quadraport needle with improved intravitreal drug dispersion.
    Asami T; Wong SC; Mitchell PC; Tokunaga CC; Chen YH; Dang L; Giblin FJ; Trese MT
    Retina; 2012 Jun; 32(6):1222-5. PubMed ID: 22596098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.